Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.67 |
| ▸ | KDR | P35968 | 13/20 | 0.55 |
| ▸ | KIT | P10721 | 7/20 | 0.55 |
| ▸ | PDGFRA | P16234 | 7/20 | 0.55 |
| ▸ | FLT1 | P17948 | 5/20 | 0.55 |
| ▸ | FLT4 | P35916 | 4/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.55 |
| ▸ | PLK4 | O00444 | 1/20 | 0.55 |
| ▸ | AURKA | O14965 | 1/20 | 0.55 |
| ▸ | GAK | O14976 | 1/20 | 0.55 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.55 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.55 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | PIP5K1C | O60331 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4427732 | 0.93 | BTK (0.75) | BTKKDRKITPDGFRAFLT1 | |
| SCHEMBL724300 | 0.92 | BTK (0.79) | BTKKDRKITPDGFRAFLT1 | |
| Hydrochloric Acid SCHEMBL159486 | 0.92 | BTK (0.77) | BTKKDRKITPDGFRAFLT1 | |
| Hydrochloric Acid SCHEMBL935691 | 0.91 | BTK (0.76) | BTKKDRKITPDGFRAFLT1 | |
| SCHEMBL15973689 | 0.85 | BTK (0.62) | BTKKDRKITPDGFRAFLT1 | |
| SCHEMBL29223177 | 0.84 | BTK (0.56) | BTKKDRKITPDGFRAFLT1 | |
| SCHEMBL2489529 | 0.84 | BTK (0.54) | BTKKDRKITPDGFRAFLT1 | |
| SCHEMBL17135511 | 0.82 | BTK (0.58) | BTKKDRKITPDGFRAFLT1 | |
| SCHEMBL12575010 | 0.80 | BTK (1.00) | BTKKDRKITPDGFRAFLT1 | |
| SCHEMBL725544 | 0.79 | KDR (0.85) | KDRKITPDGFRAFLT1FLT4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2608790-A1 | PHARMACEUTICAL COMBINATION OF A VEGFR INHIBITOR AND A MEK INHIBITOR USEFUL FOR TREATING CANCER | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2013-07-03 | — | — | EP | disclosed |
| WO-2012027438-A1 | PHARMACEUTICAL COMBINATION OF A VEGFR INHIBITOR AND A MEK INHIBITOR USEFUL FOR TREATING CANCER | GLAXOSMITHKLINE LLC (US) | 2012-03-01 | — | — | WO | disclosed |